Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSCs Injections for Liver Cirrhosis
NCT02297867Phase 1Completed
- Sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of GXHPC1 in Liver cirrhosis (LC), sponsored by Gwo Xi Stem Cell Applied Technology Co., Ltd. Primary endpoint: Model for End-Stage Liver Disease. Started Jul 2015; status: completed.
02
Drugs
GXHPC1
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02297867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297867.